Baltimore, MD, July 6, 2021 — Tens of thousands of American lives end prematurely every year due to opioid overdoses, leaving families shattered. Dr. Paul Christo, anAssociate Professor in the Division of Pain Medicine at the Johns Hopkins University School of Medicine, wants to remind those battling addiction to make use of telemedicine and tele-mental health services that emerged as valuable resources during the pandemic, and he adds, clinicians need to advocate to their patients that online treatment options are available.
Dr. Christo, who is on the frontlines working to curb the impact of the opioid crisis, also wants patients to know that critical medications for maintaining sobriety can now be prescribed by telehealth or telephone.
"The number of fatalities from opioid-related overdoses could be nearly 30 percent higher than reported due to missing information or incomplete death records,” he says. “The worst fear is that because of social isolation, people are not being found or treated immediately."
The opioid epidemic today progressed in three phases, according to the Centers for Disease Control and Prevention. The first involves deaths caused by prescription opioids, the second, an increase in heroin use, and the third, a surge in the use of synthetic opioids or fentanyl. Experts say the U.S. is right in the middle of the third phase of the epidemic, due to the increasing availability of fentanyl and increasing rates of overdose deaths involving synthetic opioids.
According to a recent study there were 632,331 drug overdoses between 1999 and 2016. Most of these deaths (78.2 percent) were drug overdoses with known drug classification. Moreover, 21.8 percent were unclassified drug overdoses. A further investigation revealed that for unclassified drug overdoses, 71.8 percent involved opioids, translating to 99,160 additional opioid-related deaths.
There were over 70,000 drug overdose deaths in 2017, according to an estimate from the CDC. Based on findings from the new study, over half of those deaths — about 47,000 — are suspected of having involved opioids.
Another study on opioid overdoses found that the number of drug overdose deaths decreased by 4 percent from 2017 to 2018. In 2018, more than 67,000 people died from drug overdoses, making it a leading cause of injury-related death in the United States. Almost 70 percent involved a prescription or illicit opioid of those deaths.
“COVID 19 impacted the drug supply chain by closing borders on some regions, and it led to the higher death rate,” Dr. Christo explained. He added that drugs become more challenging to get, and the potency of overdose goes up. It also impacts the price, everything goes up, and in that sense, it becomes more deadly each day, according to Dr. Christo.
About Dr. Paul Christo
Dr. Paul Christo serves as Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital. He is the author of Aches and Gains, A Comprehensive Guide to Overcoming Your Pain. Dr. Paul Christo also hosts an award-winning, nationally syndicated SIRIUS XM radio talk show on overcoming pain called, Aches and Gains®. For more information about Dr. Paul Christo. Please visit www.paulchristomd.com.
###
Patricia’s Story: Surviving Stage IV Adolescent Cancer
Baltimore, MD, July 6, 2021 — “Pretty girls don’t get cancer,” the doctor assured M. Patricia Diaz over 30 years ago. At the age of just 16, Diaz was scared and uncomfortable. However, the doctor’s words were meant to reassure her — and at the time, they worked. Patricia had been bracing for bad news, and now she felt relieved.
Two months later, she was diagnosed with stage IV terminal cancer.
Pretty Girls Don’t Get Cancer is Diaz’s candid, compelling story of overcoming the medical odds and transforming herself — mind, body and spirit — as a way of nurturing her ongoing healing process. Diaz experienced a year of social isolation (due to her compromised immune system at the time) during what should have been the most carefree, enjoyable time in her young life. Her journey toward authentic recovery would require spiritual growth and the kind of introspection that typically comes with maturity and hindsight.
“Isolation, at first a burden, in time, turned into a precious gift,” Diaz reflects. “It gave me space and silence, and it shone the light into the corners of my soul that were comfortably dim. … I was alive — I was breathing, and that insight made all the difference for me to make the best of the time I had to spend with ‘me.’”
Pretty Girls Don't Get Cancer does not sugarcoat the agony of the tests and treatments that Diaz endured, but she keeps the narrative conversational and relatable, with Latin American nuances and sprinkles of adolescent humor. Part coming-of-age, part motivational memoir, her storyis a testament to the power of a strong community, personal resiliency and grains of faith in the face of a cancer diagnosis. Diaz shows readers how her illness affected her life, her family and the community, and how restoring her physical health was only the first step toward healing.
About the Author
M. Patricia Diaz is an author, health-supportive chef and human resources consultant. Her wellness journey began in 1989 when she was diagnosed with stage IV terminal cancer. During the most difficult time in her life, and with the help of friends, family and life mentors, she turned to yoga, plant-based diets and other alternative techniques to manage her crisis and then gently restore her health after cancer treatments.
The lessons Diaz learned, and years of yoga practice, led to an enthusiasm for well-being, a search for a depth of knowledge, and provided a compass for her life and career. She trained in a plant-based chef program at the Natural Gourmet Institute in New York City and completed a 200-hour Yoga Teacher Training Program at Kripalu Center for Yoga and Health.
She is passionate about teaching the foundations of yoga and the basics of plant-based diets. She loves to help others connect with their inner wellness coach, and she believes that a genuine practice starts with a strong foundation honoring the principles of “ahimsa'” — first do no harm.
For more information, please visit https://mpatriciadiaz.com, or follow the author on Facebook (MPatriciaDiaz); Twitter (@mpatriciadiaz01); or Instagram (prettygirlsdontgetcancer).
Pretty Girls Don’t Get Cancer
Publisher: BookBaby
ISBN-10: 1098312244
ISBN-13: 978-1098312244
Available from Amazon.com, BN.com, Apple Books and many other online retailers
###
Canada Diagnostic Centres and Novacap partner to accelerate the national expansion of one of Canada's largest medical imaging groups
MONTREAL, July 6, 2021 /CNW Telbec/ - Novacap, one of Canada's leading private equity firms, today announced it has invested in Canada Diagnostic Centres (CDC), an Alberta-based provider of medical imaging services, and one of the largest companies of its kind in Canada. Novacap intends to support CDC's goal to expand its services from coast to coast, reinforcing their reputation as a leading diagnostic imaging provider in Canada.
With a total of 18 outpatient clinics in Alberta and British Columbia, CDC provides care during 500,000 patient-visits annually for such services as ultrasound, mammograms, X-rays, MRI, CT scans, and image-guided pain management. Thanks to a sophisticated physician-led management team, the Centres have a robust operation in the competitive Alberta landscape.
CDC's leadership and shareholders will remain in place, leveraging the investment from Novacap to pursue their goal of providing patients throughout Canada with access to top level care and technology.
"I am incredibly proud of the high-quality patient care provided by my colleagues at CDC, including my fellow physicians, our superb team of technologists, and many other valued staff. We are very pleased to have Novacap recognize and support this work, and help us to extend the reach of this commitment to exceptional patient care further into other provinces and across Canada" said Dr. Robert Davies, Medical Director and CEO, CDC.
"Such an investment opens new doors and turns our ambitions into tangible objectives. We plan to start looking for great partners in other provinces who share our vision for quality, timely access to these services, and are interested in being part of a national collaboration of professionals making positive differences in patients' lives," said Lorne Paperny, President and Founder, CDC.
Novacap shares CDC's vision to create a physician-led national champion in diagnostic imaging and image-guided procedures.
"Today we announce a significant partnership with these exceptional radiology clinics. Our teams are committed to making CDC's vision come to life and to build its Canada-wide practice from their headquarters in Calgary," said Marc Paiement, Senior Partner, Novacap. "This marks Novacap's third investment in Alberta in the last 12 months and reaffirms our interest in growing partnerships in Western Canada," he added.
"Our investment in CDC is Novacap's second into the growing and diverse medical imaging sector," said Heather Shantora, Principal at Novacap, overseeing healthcare operations. "With the health care needs of Canadians continuing to grow over time, we believe that every province can benefit from CDC's high standards of quality and service."
Deloitte acted as the advisor for CDC.
About Novacap
Founded in 1981, Novacap is a leading Canadian private equity firm with more than C$8B of AUM that has invested in more than 100 platforms and 150 add-on acquisitions. Applying its sector-focused approach since 2007 in TMT, Industries and now Financial Services, Novacap's deep domain expertise can accelerate company growth and create long-term value. With experienced, dedicated investment and operations teams as well as substantial funding, Novacap has the resources and knowledge to build world-class businesses. Novacap has offices in Brossard, Quebec and Toronto, Ontario. For more information, please visit novacap.ca.
About Canada Diagnostic Centres
Every year 5,700 practitioners refer nearly 500,000 patients to Canada Diagnostic Centres (CDC) and trust their expert radiologists and clinicians to perform more than a million tests. CDC has worked to build that trust every day since opening its first clinic in 1993. Today, with more than 500 expertly trained professionals in 18 clinics across Alberta and British Columbia, CDC provides patients with services that include ultrasounds, mammograms, X-rays, MRI, CT scans, and image-guided pain management. For more information, please visit canadadiagnostics.ca.
SOURCE Novacap Management Inc.
New life sciences company takes aim at obesity, toxic effects of overnutrition
NIMIUM Therapeutics launches in Montreal
MONTREAL, July 6, 2021 /CNW/ - A new made-in-Canada life sciences company, Nimium Therapeutics, has been launched to develop novel therapies for patients with cardiometabolic diseases.
The company's foundational technology is based on the cutting-edge research of the laboratory of Dr. Marc Prentki, the Canada Research Chair in Diabetes and Metabolism, Director of the Montreal Diabetes Research Center, and Principal Scientist at the Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM). Dr. Prentki is an internationally renowned expert in obesity and diabetes whose research team has discovered that an enzyme, glycerol-3-phosphate phosphatase (G3PP), plays a key role in sugar, fat and energy metabolism.
This research was further advanced by adMare BioInnovations, Canada's global life sciences venture, which identified multiple series of hits that activate the human G3PP enzyme. NIMIUM founders obtained the IP rights to the hits from adMare, and are now developing them for multiple cardiometabolic diseases.
NIMIUM is led by life sciences veteran, Dr. Philippe Walker, who has held numerous executive-level R&D roles with AstraZeneca, and was the Founder and Chief Scientific Officer of the NEOMED Institute. He commented, "We are excited to launch this new venture based on the world-leading research of Dr. Prentki and his team. From obesity to type 2 diabetes, and other diseases such as chronic kidney disease and non-alcoholic fatty liver disease, there is a global epidemic related to the toxic effects of overnutrition. Through NIMIUM, we aim to address this health crisis by developing a new therapeutic approach that will reduce the effects of excess caloric intake, and that should promote healthy aging."
Gordon C. McCauley, President and CEO of adMare added, "At adMare, our job is to build Canada's national life sciences industry by building new companies. NIMIUM is an excellent example of how we're successfully doing that – proactively identifying research at leading Canadian academic research institutions, and advancing it to the point it can form a solid foundation for a new life-sciences company. We are extremely pleased to be supporting the research of Dr. Prentki and the launch of NIMIUM; and look forward to seeing the impact the company is sure to have on Canada's life sciences ecosystem, and on the lives of patients worldwide.
ABOUT NIMIUM THERAPEUTICS NIMIUM Therapeutics is a Montreal biotech focused on the development of an innovative therapeutic to treat cardiometabolic diseases. The research is based on glycerol-3-phosphate phosphatase (G3PP), an enzyme found to play a central role in glucose, lipid, and energy metabolism. NIMIUM has partnerships with adMare BioInnovations, a Canadian organization that offers expertise, infrastructure, and capital to help build life-sciences companies. NIMIUM has received funding from Investissement Quebec. For more information, visit www.nimium.ca
ABOUT ADMARE BIOINNOVATIONS adMare BioInnovations is Canada's Global Life Sciences Venture, building the Canadian life sciences industry from sea to sea. We do this by sourcing therapeutically and commercially promising research from leading academic and biotech partners to create new companies of scale, providing specialized expertise and infrastructure to help existing companies scale up, and driving the growth of those companies into Canadian anchors by training the next generation of highly-qualified personnel. Our 20+ portfolio companies have attracted more than $1.2B of investment, and have a combined value of over $3B. For more information, visit www.admarebio.com
SOURCE adMare BioInnovations
The WiseGuide App: Gain Confidence, Find Happiness and Achieve Success
Fort Myers, FL, July 6, 2021 — Effective Learning Systems, the company that pioneered the practice of Productive Meditation more than 45 years ago, recently announced the launch of their first mobile app, WiseGuide, putting the company’s entire library of powerful, time-tested self-improvement techniques at everyone’s fingertips.
WiseGuide goes beyond the benefits of traditional mindfulness and meditation teachings to deliver a vast library of targeted, impactful programs that can help users achieve specific, life-changing personal and professional goals, including boosting athletic performance, building healthier relationships, cultivating better concentration and managing addictions.
“Most people experience positive results immediately and remarkable life-transformation with regular, consistent use,” said Effective Learning Systems founder Bob Griswold.
Features of the WiseGuide App include:
- Over 120 prescriptive titles that address specific goals, including smoking cessation, weight control, stress management, better sleep and much more
- A children’s collection for self-image and self-esteem
- Effective studying and test taking for children from grade school through college
- Programs to listen to while driving, exercising, working or even sleeping
- Works on any iOS or Android mobile device
It is never too late to break bad habits, overcome fears, manage stress or improve virtually any other aspect of life, and it’s never been easier. The WiseGuide App can help people use the power of their own minds to take control and make lasting improvements. And all they have to do is listen.
The WiseGuide App was developed by Effective Learning Systems, whose founder Bob Griswold has been helping people harness the power of their own minds to make transformative changes for more than 45 years. His unique approach to meditation, guided imagery, positive affirmations, relaxation, self-hypnosis and more make his programs uniquely effective.
MuscleTech Announces Partnership With Olympic Bound Canadian Gymnast Ellie Black
The top Canadian female gymnast of all time teams up with sports nutrition and fitness leader MuscleTech in preparation for her third Olympic Games
New York, New York, July 06, 2021 (GLOBE NEWSWIRE) -- Oakville, ON (July 6, 2021) – Iovate Health Sciences International Inc., under its internationally recognized MuscleTech (www.muscletech.com) sports nutrition brand, has announced a partnership with Canadian gymnast Ellie Black who will be heading to the Tokyo Summer Olympics. The 25-year-old from Halifax, Nova Scotia is the most decorated female Canadian gymnast and the first Canadian gymnast to win a World Championships All-Around medal. At the 2016 Olympics, Black finished 5th in the individual All-Around, the highest placement ever recorded by a Canadian. As part of her partnership with MuscleTech, she will be helping the sports nutrition and fitness leader tell its “Strength Redefined” story. The powerful gymnast will also be using MuscleTech 100% Grass Fed Whey and Iso Whey Clear proteins to fuel her training sessions in preparation for the Tokyo Summer Olympics.
Black, whose self-proclaimed motto is: “Dream big, don’t let anyone else set your limits”, will look to become the first Canadian woman to win an Olympic medal in traditional gymnastics. Heading into these Games, there was some uncertainty as to whether Black would even be able to compete again after the elite athlete suffered a severe injury and setback at the 2019 World Artistic Gymnastic Championships, just months before the 2020 Olympics. But, after a year of careful recovery, hard work, and dedication, Black will once again be pursuing Olympic glory in the 2021 rescheduled Games, having previously represented her country at the world’s top sports competition in both 2012 and 2016.
“As an athlete, using supplements compliments my training. I love MuscleTech (especially their Whey protein products) because I know I am fueling my body with clean ingredients, delicious flavors, and recipes that work for my body and lifestyle,” said Black.
The proud Canadian and Nova Scotian is a 2017 World Championships Silver All-Aaround Medalist, a 2018 Commonwealth Games all-around champion, a two-time Pan American Games All-Around Champion, and a seven-time Canadian National All-Around Champion. In 2018, Black was named one of the greatest 15 athletes in Nova Scotian history and was awarded the Order of Nova Scotia for her contributions to the Province. She is also an advocate for female empowerment, and will be using her platform and this partnership to further her passion for this cause.
“We are thrilled to welcome Ellie to Team MuscleTech,” said Jennifer Bremner, General Manager of MuscleTech at Iovate Health Sciences International Inc., “Ellie perfectly embodies what MuscleTech represents. Physical strength, emotional fortitude, grit and determination.”
Black and MuscleTech are committed to bringing active nutrition and human potential together for a greater purpose. For more than twenty-five years, MuscleTech has fueled those who want to raise the bar, helping to optimize human performance. The brand’s innovative line of performance supplements meets the needs of everyone from fitness enthusiasts to elite athletes who are training to improve their strength, endurance, and power.
MuscleTech supplements are made with only high-quality ingredients and the brand is dedicated to continuously researching, developing, patenting, producing, and globally marketing safe and effective diet and sports supplements to assist people in achieving their personal fitness goals.
For more information on MuscleTech products, visit www.muscletech.com. Also follow us at Facebook.com/MuscleTech and @MuscleTech on Twitter and Instagram for product and athlete information, news and updates, diet and training tips, special promotions and more.
About Iovate Health Sciences International Inc.
Iovate Health Sciences International Inc. (“Iovate”) is a dynamic, leading-edge nutritional company that delivers some of the highest quality, most innovative and effective active nutrition products in the world. With brand innovations such as MuscleTech, Iovate is committed to being the number one active nutrition company in the world. MuscleTech was born out of an obsession to redefine the limits of science and human potential.
Due to our commitment to research, development and innovation, we’ve been globally recognized as one of the leading sports nutrition brands in the industry, and continue to be one of the elite brands redefining performance through cutting-edge products and high-quality ingredients.
Headquartered in Oakville, Ontario, Canada, Iovate is a family of more than 300 employees, six leading nutritional brands and growing, with effective products that can be found across the globe.
Arthritis Liaison Model of Care: Step in the Right Direction for First Nations People with Arthritis
VANCOUVER, BC, July 5, 2021 /CNW/ - A collaborative study has found a way to bridge the gap between First Nations people living with arthritis and clinicians to improve quality of care.
The arthritis liaison model of care was developed with a First Nations community to support culturally relevant, patient-centred care plans and then tested for one year.
"We codeveloped the liaison model of care with a First Nations community and found that it assisted First Nations people with arthritis in navigating health services to better take care of their needs and focus on their personal care plans," said Dr. Cheryl Barnabe, a rheumatologist and senior scientist at Arthritis Research Canada. "Both the patients who participated in our study and the community health care providers found it to be valuable."
Navigating the health system when you are diagnosed with a chronic disease can be confusing and challenging. Inequities in determinants of health related to the legacy of colonization also affect the health status of First Nations people diagnosed with arthritis.
Health care providers either consciously (through disregard for cultural values) or unconsciously (by failing to provide culturally relevant care) disempower patients. This can affect quality of care over time and undermine efforts to support effective disease management and wellbeing.
Arthritis is a leading cause of disability in First Nations communities and is often accompanied by other chronic diseases. Existing care models prioritize accessibility to specialty care for treatment, whereas patient-centred approaches support broader health goals.
First Nations populations have an increased prevalence, severity and undertreatment of arthritis.
Therefore, novel ways of delivering relevant care that address social, geographical and economic barriers are needed to improve outcomes among First Nations people living with different types of this disease.
Want to learn more about this important research? Click here to read the full research paper.
ABOUT ARTHRITIS RESEARCH CANADA:
Arthritis Research Canada is the largest clinical arthritis research institution in North America. Our mission is to transform the lives of people living with arthritis through research and engagement. Arthritis Research Canada's scientific director, Dr. Diane Lacaille is leading a team of over 100 researchers, trainees and staff whose world recognized research is creating a future where people living with arthritis are empowered to triumph over pain and disability. Arthritis Research Canada is conducting research across Canada in British Columbia, Alberta and Quebec and is affiliated with five major universities: University of British Columbia, Simon Fraser University, University of Calgary, Université Laval, and McGill University. Arthritis Research Canada is leading research aimed at arthritis prevention, early diagnosis, new and better treatment, and improved quality of life.
SOURCE Arthritis Research Canada
Mirroring the weather, Fraser Valley’s hot housing market cooled slightly in June going from a boil to a simmer
SURREY, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) -- Sales on the Fraser Valley Real Estate Board’s Multiple Listing Service® (MLS®) remained robust in June however, for the first time since last September, monthly sales did not break a historical record.
In June, the Board processed 2,247 sales on its MLS®, a decrease of 24 per cent compared to May and a 31 per cent increase compared to June of last year. Sales continued to remain elevated compared to a typical June – 22 per cent above the ten-year average.
Larry Anderson, President of the Board, said, “In June, we shifted from an extreme seller’s market to a strong seller’s market. Although demand for Fraser Valley homes remains very high – over 40 per cent of active listings sold in June – we’re seeing the market settle down giving buyers and sellers more room to maneuver.
“We’re now seeing more subject offers and for the first time in months, we’re starting to see price reductions.”
In June, the Board received 3,108 new listings, a decrease of 10 per cent compared to last year, and a decrease of 21 per cent compared to May 2021. The month ended with total active inventory sitting at 5,474, a 7 per cent decrease compared to May, and 22.5 per cent fewer than June 2020.
Anderson continued, “A lack of supply continues to be the single largest factor affecting the market. Simply put, to meet current demand and get back to balance, we need about 3,500 more active listings in our region.”
Baldev Gill, Chief Executive Officer of the Board, added, “Effective July 1, as part of Stage 3 of BC’s Restart Plan, REALTORS® are again allowed to hold in-person showings and open houses while continuing to adhere to public safety recommendations.
“For more than a year, our industry has put tremendous effort into keeping the public safe and we will remain vigilant. We’d like to express our sincere appreciation to the public for your continued support and cooperation.”
Across Fraser Valley, in June, the average number of days to sell a single-family detached home was 17 and a townhome was 12 days. Apartments took, on average, 21 days to sell.
MLS® HPI Benchmark Price Activity
Single Family Detached: At $1,324,400, the Benchmark price for an FVREB single-family detachedhome increased 0.1 per cent compared to May 2021 and increased 33.2 per cent compared to June 2020.
Townhomes: At $678,400, the Benchmark price for an FVREB townhome increased 1.3 per cent compared to May 2021 and increased 21.2 per cent compared to June 2020.
Apartments: At $493,500, the Benchmark price for an FVREB apartment/condo increased 1.0 per cent compared to May 2021 and increased 13.4 per cent compared to June 2020.
The Fraser Valley Real Estate Board is an association of 4,014 real estate professionals who live and work in the BC communities of Abbotsford, Langley, Mission, North Delta, Surrey, and White Rock. The FVREB will mark its 100-year anniversary in October 2021.
Only year on year vaccine investmentcan contain new COVID strains
Booster jabs from tweaked COVID vaccines are a must until a universal vaccine breakthrough is made, according to the World Nano Foundation (WNF).
And the not-for-profit promoter of nanotechnology research called for continued heavy investment in vaccine research.
WNF co-founder Paul Sheedy said: "Current COVID-19 vaccines are designed to protect us against emerging variants, but it's still possible for new variants to develop and bypass current vaccines, causing more deaths and lockdowns.
"Many believe the solution lies in universal vaccines able to immunize us against all strains of a disease, but this technology is not yet available.
"Think of the virus as one of those lollipop displays in shops, with the sticks coming out from the centre of the virus as lollipops in the stand. Minor mutations occur on the 'lollipop sticks' and can be targeted by current vaccine technology, but similar to how the 'flavour' of lollipops may change on a display stand, new variants of the virus will appear that current vaccines may not be able to recognize and prevent."
This model shows the outward lollipop sticks pointing out from the virus.
"A universal vaccine would instead recognise the 'lollipop stand' instead of the individual flavours. It doesn't care what the new variants or 'flavours' are or if they change, so it will arm the body to attack anything from that virus family or 'the stand' itself.
However, a universal vaccine that targets the 'stand' instead of the changing 'flavours' is very hard to develop. Vaccine development isn’t easy, especially when you consider we still haven't developed vaccines against diseases such as HIV, which has been around since the 1980s."
Sheedy believes the universal vaccine 'code' will be cracked eventually but, in the meantime, medical science must rely upon continual modification of vaccines, in the same way as influenza is controlled:
"Although we cannot yet be proactive through the application of a universal vaccine, we can plan to the best of our ability, quickly identifying or anticipating new strains and tweaking vaccines year on year to protect us continually."
Sheedy believes this strategy is more than achievable, especially after 20-21 mass vaccine rollout. The Pfizer, Moderna and AstraZeneca vaccines took less than a year to develop and distribute after intense funding fuelled by the COVID-19 outbreak.
Investment into healthcare technology is already rising, soaring 47% to a new high of $51 billion last year, and figures show the global healthcare industry is expected to be worth over $10 trillion by 2022 on a 10-year upward trajectory.
Kojo Annan, co-founder of the Vector Innovation Fund (VIF), believes if we are to improve our healthcare systems and vaccine technology, investment on this scale must be maintained. VIF recently launched a $300 million international sub-fund for pandemic protection and future healthcare, which is part of a wider billion-dollar fund for enabling technologies for sustainability and longevity of life.
"In 30 years, our healthcare systems could be improved to an unrecognisable level compared to now, as long as we invest. Vaccines could be developed in days instead of months, human trials may no longer be required, and we could create therapies to treat and cure patients suffering from some of the world's deadliest diseases.
"Healthtech companies are already delivering some game-changing innovations, and a flood of these could come through soon if there is continued investment."
For further information or interviews with The World Nano Foundation or Vector Innovation Fund or Cityzenith please contact: steve.philp@worlddigitalfoundation.com or +44 7973 159065
The World Nano Foundation (WNF) is a not-for-profit membership organisation with 75,000 subscribers and users in 40 countries working on international commercialisation of nanoscale technologies in 16 industry sectors and collaborates with a wide variety of partners, maximising support and funding bringing advanced technology to the world and commerce. This is supported by many industries and academic groups developing and creating a legacy for enabling technology innovation.
Vector Innovation Fund (VIF) is a Reserved Alternative Investment Fund (RAIF) specialising in support for technology companies able to transform and protect global markets, notably in global healthcare, enabling technology, sustainability, and longevity aligned to the UN's SDG principles. VIF’s first sub-fund focuses on ‘Pandemic Protection’, and preparedness for future healthcare technology. This fund structure is domiciled in the world-renowned Luxembourg jurisdiction, and is only open to international accredited and professional investors, such as family offices, UHNW, private placement investors, pension funds, international banks, ESG investors and sovereign wealth funds. The General Partners have an excellent track record in industry, healthcare, technology and investment, with 21 exits and a total value creation of $2.4billion, including two successful IPOs.
Tips for Better Recovery as You Train for a Triathlon
Training for a triathlon is one of the hardest things you're ever likely to put your body through. The harder you push your body, the more important it is to support proper recovery in order to avoid serious injuries. Here are four tips for promoting better recovery as you train for a triathlon.
Make Sure Your Nutrition Is Solid
Triathlon training will necessarily burn calories quickly and put a significant strain on your muscles. To balance these pressures off, be sure that you're taking in enough calories and getting all of the nutrients you need to support good muscle health. If you have any doubts about your current diet, talk to a nutritionist to get a proper eating plan to follow while you train.
Give Yourself Rest Days
Although it may seem like training every day is the fastest way to meet your fitness goals, you also need to give your body time to rest. Generally, it's a good idea to train intensely 3-4 days per week, then give yourself the remaining time to rest and recover. On these rest days, your body will build new muscle and prepare itself for the next training session.
If You Get Injured, Have It Addressed Quickly
Because of the intensity of triathlon training, there's at least a serious chance you could injure yourself at some point in the process. If this does occur, be sure to seek help immediately. An injury that is treated promptly should recover quickly, but it could become a serious problem if you try to continue training before it's fully healed. Some time off, an anti-inflammatory or some lightphysical therapy now could save you from permanent injury later on.
Remember That Consistency Is Key
As your body becomes more used to your training routine, you'll find that it's easier to recover between workouts. Getting to this point requires consistently sticking to your training schedule, even if you're a bit sore or just aren't feeling very energetic. With consistent training, you'll eventually be able to recover quickly and maximize the results of your exercise regimen.
By following these tips, you can support your body properly as it recovers during triathlon training. Keep in mind that it will take you time to reach your goals and complete your first triathlon. With dedication, though, you can keep your body in top shape and prevent injury while you progress toward your fitness goals.
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
